Seizure management in the setting of hepatic disease.

  • Jane G. Boggs
  • Published 2011 in Current treatment options in neurology


OPINION STATEMENT In the past 20 years, many antiepileptic drugs (AEDs) have been marketed that are not significantly metabolized by the liver, but some patients still require the use of older and more metabolically complex AEDs for optimal seizure control, and current economic and insurance-coverage limitations have forced many patients to switch to less… (More)
DOI: 10.1007/s11940-011-0129-6


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics